In this podcast, Andrew Limper, MD, discusses his latest research on 2 antifibrotic drugs for the treatment of idiopathic pulmonary fibrosis, which was recently published by the American Thoracic Society. More at: www.consultant360.com/pulmonology.

Andrew Limper, MD, on the Effectiveness of Antifibrotics for IPF

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Andrew Limper, MD, on the Effectiveness of Antifibrotics for IPF

Sign up to save your podcasts

Andrew Limper, MD, on the Effectiveness of Antifibrotics for IPF

Andrew Limper, MD, on the Effectiveness of Antifibrotics for IPF

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast